Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 26 Prostatic Neoplasms 24 Brain Neoplasms 21 Neoplasms 13 Glioma 10 Head and Neck Neoplasms 8 Pancreatic Neoplasms 7 Glioblastoma 6 Lung Neoplasms 5 Colonic Neoplasms 5 Carcinoma, Hepatocellular 5 Astrocytoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Lymphoma 4 Central Nervous System Neoplasms 4 Urinary Bladder Neoplasms 3 Triple Negative Breast Neoplasms 3 Spinal Cord Neoplasms 3 Sarcoma 3 Liver Neoplasms 3 Disease 3 Retinoblastoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Oligodendroglioma 2 Neurofibromatosis 1 2 Meningioma 2 Lymphoma, Non-Hodgkin 2

Interventions

Radiosurgery 79 Capecitabine 77 Oxaliplatin 74 Fluorouracil 69 Bevacizumab 69 Gemcitabine 67 Leucovorin 61 pembrolizumab 53 Nivolumab 53 Paclitaxel 48 Irinotecan 47 Radiotherapy 45 Cisplatin 44 Everolimus 38 Magnetic Resonance Spectroscopy 36 Drug Therapy 36 Docetaxel 36 Cyclophosphamide 35 Cetuximab 35 Ipilimumab 32 Carboplatin 32 Trastuzumab 31 Sunitinib 30 Sorafenib 26 Erlotinib Hydrochloride 25 Doxorubicin 23 Surveys and Questionnaires 20 Surgical Procedures, Operative 20 Specimen Handling 20 Biopsy 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasm Metastasis × Magnetic Resonance Imaging × Clear all

NCT02706964 2022-06-30

BCMetPats

University of Florida

Phase NA Completed

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡